Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997

AIDS

Volumn 13, Issue 15, 1999, Pages 2157-2164

  Beck, Eduard J ^a,l   Mandalia, Sundhiya ^a   Williams, Ian ^b   Power, Amanda ^a   Newson, Roger ^a   Molesworth, Anna ^c   Barlow, David ^d   Easterbrook, Philippa ^a   Fisher, Martin ^e   Innes, John ^f   Kinghorn, George ^g   Mandel, Bibhat ^h   Pozniak, Anton ⁱ   Tang, Alan ^j   Tomlinson, David ^k  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^f BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^g ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^h NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

ⁱ KING S COLLEGE HOSPITAL   (United Kingdom)

^j ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^k ST MARY S HOSPITAL   (United Kingdom)

^l IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

more..

Author keywords

Antiretroviral therapy; HIV; Hospital services; Morbidity; Mortality

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITAL SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONITORING; MORBIDITY; MULTICENTER STUDY; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0032710410     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199910220-00020     Document Type: Article

References (31)

1. Public Health Laboratory Service, HIV and STD Division AIDS and HIV infection in the United Kingdom. Monthly report. Communicable Disease Report 1998, 8:278-279.
2. Mocroft A, Vella S, Benfield A, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998, 352:1725-1730.
3. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860.
4. Hogg RS, O'Shaughnessy MV, Cataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1998, 349:1294.
5. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. JAMA 1998, 280:78-86.
6. Gazzard B, Moyle G, on behalf of the BHIVA Guidelines Writing Committee. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1998, 352:314-316.
7. Hirschel B, Francioli P. Progress and problems in the fight against AIDS. N Engl J Med 1998, 338:907-908.
8. Beck EJ, Tolley K, Power A, et al., for the NPMS Steering Group. Use and cost of HIV service povision in England, 1996. PharmacoEconomics 1998, 14:639-652.
9. Beck EJ, Griffith R, Fitzpatrick R, et al. Patient satisfaction of HIV service provision in NPMS hospitals: the development of a standard satisfaction questionnaire. AIDS Care, 1999; 11:331-343.
10. Public Health Laboratory Service AIDS Centre. AIDS surveillance and HIV death clinical report form. London, UK: PHLS Communicable Disease Surveillance Centre; 1993.
11. SAS/STAT User's Guide, Version 6, 4th Edn. Cary, NC, USA: SAS Institute Inc.; 1990.
12. Molesworth AM. Results of a survey of diagnosed HIV infections prevalent in 1996 in England and Wales. Commun Dis Public Health 1998, 1:271-275.
13. Beck EJ, Pozniak A, Molesworth A, et al. Changing cost of English HIV service provision 1996-1997. Int J STD AIDS 1999, 10:357-362.
14. Beck EJ, Kennelly J, McKevitt C, et al. Changing use of hospital services and costs at a London AIDS referral centre 1983-1989. AIDS 1994, 8:367-377.
15. Beck EJ, Whitaker L, Kennelly J, et al. Changing presentation and survival, service utilization and costs for AIDS patients: insights from a London referral centre. AIDS 1994, 8:379-384
16. HIV and STD Division, Communicable Disease Surveillance Centre. AIDS/HIV quarterly surveillance tables: UK data to the end December 1997. Colindale, UK: Public Health Laboratory Service AIDS Centre; 1998. Tables 4, 4a and 5.
17. Beck EJ, Mandalia S, Miller DL, Harris JRW. Hospital service intervention and improving survival of AIDS patients, St Mary's Hospital, London 1982-91. Int J STD AIDS 1998, 9:280-290.
18. Torres RA, Barr M. Impact of combination therapy for HIV infection on inpatient census. N Engl J Med 1997, 336:1531-1532.
19. Beck EJ. The prospects of setting up a Singaporean prospective monitoring system on the use, cost and outcome of HIV service provision: 1997 Health Manpower Development Plan Report. London, UK: Department of Epidemiology and Public Health, Imperial College School of Medicine at St Mary's; 1997.
20. Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS defining events and hospitalizations in 10 French AIDS reference centres. AIDS 1997, 11:F101-F105
21. Beck EJ, Flori YA, Geoffard PY, Power A, Bourdillon F. Uptake of combination anti-retroviral therapy during 1996 and 1997: an Anglo-French comparison. 12th World AIDS Conference. Geneva, Switzerland, June-July 1998 [Abstract 42289].
22. Beck EJ, Tolley K. Financing HIV services in England: estimated impact of the cost of anti-retroviral therapy. Int J STD AIDS 1998, 9:512-517.
23. Ledergerber B, Telenti A, Egger M, for the Swiss HIV Cohort Study. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. BMJ 1999, 319:23-24.
24. Pakker NG, Kroon EDMB, Roos MTL, et al. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. AIDS 1999, 13:203-212.
25. Grahame-Smith H. Compliance: the patient's perspective. J HIV Comb Ther 1998, 3:72-75.
26. Miller V, Staszewski S, Nisius G, et al. Risk of new AIDS diseases in people on triple therapy. Lancet 1999, 353:463.
27. Volberding P, Lagakos S, Koch M, et al. Zidovudine in asymptomatic human immunodeficiency virus-infection: a control-led trial in persons with fewer than 500 CD4 positive cells per cubic millimetre. N Engl J Med 1990, 322:941-949.
28. Cooper DA, Emery S. Therapeutic strategies for HIV infection - time to think hard. N Engl J Med 1998, 339:1319-1321.
29. Goldberg D, Nandwani R. HIV surveillance must keep pace with advances in antiretroviral therapy. Int J STD AIDS 1998, 9:559-560.
30. Graham BS. Science, medicine, and the future: infection with HIV-1. BMJ 1998, 317:1297-1301.
31. Beck EJ. Counting the cost of HIV service provision in England: where do we go from here? J HIV Comb Ther 1997, 2:29-32.